Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Z Kardiol ; 74 Suppl 2: 103-8, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4002782

RESUMO

The diuretic effects of 30 mg muzolimine and 25 mg hydrochlorothiazide/50 mg triamterene were comparable in healthy subjects and nephrotic patients (serum albumin less than 32 g/l, creatinine clearance greater than 50 ml/min/1.73 m2). A single daily dose of 30 mg muzolimine or 25 mg hydrochlorothiazide/50 mg triamterene was sufficient in the majority of the investigated nephrotic patients. The different diuretic effects which were observed in nephrotic patients were not related to the severity of hypalbuminemia, but rather to differences in preceding diuretic treatment. Plasma levels and urinary excretion of unchanged muzolimine were comparable in healthy subjects and nephrotic patients after one day of diuretic treatment; after seven days of treatment plasma levels of muzolimine were significantly lower and urinary excretion significantly higher in nephrotic patients than in control subjects.


Assuntos
Hidroclorotiazida/uso terapêutico , Muzolimina/uso terapêutico , Síndrome Nefrótica/tratamento farmacológico , Pirazóis/uso terapêutico , Triantereno/uso terapêutico , Adolescente , Adulto , Idoso , Peso Corporal/efeitos dos fármacos , Creatinina/urina , Quimioterapia Combinada , Eletrólitos/metabolismo , Feminino , Humanos , Hidroclorotiazida/administração & dosagem , Hidroclorotiazida/farmacologia , Cinética , Masculino , Pessoa de Meia-Idade , Muzolimina/administração & dosagem , Muzolimina/farmacologia , Síndrome Nefrótica/fisiopatologia , Proteinúria/urina , Triantereno/administração & dosagem , Triantereno/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA